vs
Side-by-side financial comparison of FB Financial Corp (FBK) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $178.6M, roughly 1.7× FB Financial Corp). FB Financial Corp runs the higher net margin — 31.9% vs 12.8%, a 19.1% gap on every dollar of revenue. On growth, FB Financial Corp posted the faster year-over-year revenue change (37.0% vs -6.4%). Over the past eight quarters, FB Financial Corp's revenue compounded faster (28.9% CAGR vs 4.2%).
Fubon Financial Holding Co., Ltd. is a financial investment holding company consists of the following key subsidiaries: Fubon Asset Management, Fubon Insurance Co. Ltd., Fubon Securities, Fubon Bank, Fubon Life, Fubon Bank (China) and Fubon Bank Limited. The holding company was setup on 19 December 2001.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
FBK vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $178.6M | $295.9M |
| Net Profit | $57.0M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 39.1% | 18.4% |
| Net Margin | 31.9% | 12.8% |
| Revenue YoY | 37.0% | -6.4% |
| Net Profit YoY | 50.4% | 68.3% |
| EPS (diluted) | $1.12 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $178.6M | $295.9M | ||
| Q3 25 | $173.9M | — | ||
| Q2 25 | $76.9M | $317.0M | ||
| Q1 25 | $130.7M | $316.2M | ||
| Q4 24 | $130.4M | $297.0M | ||
| Q3 24 | $89.5M | $289.5M | ||
| Q2 24 | $128.2M | $306.1M | ||
| Q1 24 | $107.5M | $303.4M |
| Q4 25 | $57.0M | $38.0M | ||
| Q3 25 | $23.4M | — | ||
| Q2 25 | $2.9M | $-17.7M | ||
| Q1 25 | $39.4M | $22.6M | ||
| Q4 24 | $37.9M | $34.9M | ||
| Q3 24 | $10.2M | $33.6M | ||
| Q2 24 | $40.0M | $40.6M | ||
| Q1 24 | $27.9M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 39.1% | 18.4% | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | -12.7% | -7.5% | ||
| Q1 25 | 37.4% | 12.2% | ||
| Q4 24 | 38.4% | 16.0% | ||
| Q3 24 | 12.7% | 13.8% | ||
| Q2 24 | 39.7% | 15.0% | ||
| Q1 24 | 31.9% | 22.1% |
| Q4 25 | 31.9% | 12.8% | ||
| Q3 25 | 13.4% | — | ||
| Q2 25 | 3.8% | -5.6% | ||
| Q1 25 | 30.1% | 7.1% | ||
| Q4 24 | 29.1% | 11.7% | ||
| Q3 24 | 11.4% | 11.6% | ||
| Q2 24 | 31.2% | 13.3% | ||
| Q1 24 | 26.0% | 16.2% |
| Q4 25 | $1.12 | $0.24 | ||
| Q3 25 | $0.43 | — | ||
| Q2 25 | $0.06 | $-0.11 | ||
| Q1 25 | $0.84 | $0.14 | ||
| Q4 24 | $0.82 | $0.22 | ||
| Q3 24 | $0.22 | $0.21 | ||
| Q2 24 | $0.85 | $0.26 | ||
| Q1 24 | $0.59 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $172.9M |
| Total DebtLower is stronger | $212.8M | $260.0M |
| Stockholders' EquityBook value | $1.9B | $2.0B |
| Total Assets | $16.3B | $2.5B |
| Debt / EquityLower = less leverage | 0.11× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.2B | $172.9M | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | $162.2M | ||
| Q1 25 | $794.7M | $140.7M | ||
| Q4 24 | $1.0B | $177.5M | ||
| Q3 24 | $951.8M | $187.5M | ||
| Q2 24 | $800.9M | $152.9M | ||
| Q1 24 | $870.7M | $145.3M |
| Q4 25 | $212.8M | $260.0M | ||
| Q3 25 | $213.6M | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $176.8M | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $1.6B | $1.9B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.5B | $2.1B | ||
| Q1 24 | $1.5B | $2.0B |
| Q4 25 | $16.3B | $2.5B | ||
| Q3 25 | $16.2B | — | ||
| Q2 25 | $13.4B | $2.6B | ||
| Q1 25 | $13.1B | $2.6B | ||
| Q4 24 | $13.2B | $2.7B | ||
| Q3 24 | $12.9B | $2.7B | ||
| Q2 24 | $12.5B | $2.7B | ||
| Q1 24 | $12.5B | $2.7B |
| Q4 25 | 0.11× | 0.13× | ||
| Q3 25 | 0.11× | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 0.11× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $155.9M | — |
| Free Cash FlowOCF − Capex | $147.0M | — |
| FCF MarginFCF / Revenue | 82.3% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 2.74× | — |
| TTM Free Cash FlowTrailing 4 quarters | $242.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $155.9M | — | ||
| Q3 25 | $47.7M | — | ||
| Q2 25 | $71.8M | $98.2M | ||
| Q1 25 | $-16.5M | $41.1M | ||
| Q4 24 | $138.8M | $84.3M | ||
| Q3 24 | $57.8M | $63.9M | ||
| Q2 24 | $30.6M | $75.5M | ||
| Q1 24 | $36.3M | $81.0M |
| Q4 25 | $147.0M | — | ||
| Q3 25 | $45.6M | — | ||
| Q2 25 | $68.4M | $93.3M | ||
| Q1 25 | $-18.1M | $31.0M | ||
| Q4 24 | $132.3M | $77.5M | ||
| Q3 24 | $56.7M | $54.7M | ||
| Q2 24 | $28.4M | $57.5M | ||
| Q1 24 | $34.6M | $64.5M |
| Q4 25 | 82.3% | — | ||
| Q3 25 | 26.2% | — | ||
| Q2 25 | 89.0% | 29.4% | ||
| Q1 25 | -13.9% | 9.8% | ||
| Q4 24 | 101.4% | 26.1% | ||
| Q3 24 | 63.3% | 18.9% | ||
| Q2 24 | 22.1% | 18.8% | ||
| Q1 24 | 32.2% | 21.3% |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 4.4% | 1.5% | ||
| Q1 25 | 1.3% | 3.2% | ||
| Q4 24 | 5.0% | 2.3% | ||
| Q3 24 | 1.2% | 3.2% | ||
| Q2 24 | 1.7% | 5.9% | ||
| Q1 24 | 1.5% | 5.4% |
| Q4 25 | 2.74× | — | ||
| Q3 25 | 2.04× | — | ||
| Q2 25 | 24.68× | — | ||
| Q1 25 | -0.42× | 1.82× | ||
| Q4 24 | 3.66× | 2.42× | ||
| Q3 24 | 5.65× | 1.90× | ||
| Q2 24 | 0.77× | 1.86× | ||
| Q1 24 | 1.30× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FBK
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
